Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11708335 Pyrimidine compounds useful as tyrosine kinase inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 18, 2018
0
Date of Patent
July 25, 2023
0
Patent Application Number
16954792
0
Patent Citations
‌
US Patent 7223749 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
0
‌
US Patent RE41065 Alkynl and azido-substituted 4-anilinoquinazolines
0
‌
US Patent 8710068 Method of treating cancer using a survivin inhibitor
0
‌
US Patent 7863281 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
0
‌
US Patent 9295676 Mutation mimicking compounds that bind to the kinase domain of EGFR
0
‌
US Patent 7087613 Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
0
‌
US Patent 7157466 Quinazoline ditosylate salt compounds
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11708335
0
Patent Primary Examiner
‌
Rebecca L Anderson
0
CPC Code
‌
C07D 413/12
0
‌
C07D 417/12
0
‌
C07D 417/14
0
‌
C07D 239/94
0
‌
C07D 401/12
0
‌
C07D 403/04
0
‌
C07D 403/12
0
‌
C07D 405/12
0

Find more entities like US Patent 11708335 Pyrimidine compounds useful as tyrosine kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo